PMV Pharmaceuticals, Inc., a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants, announced that David H. Mack, Ph.D., President & Chief Executive Officer, will present at the Goldman Sachs Annual Global Healthcare Conference on Wednesday, June 9, 2021.
June 3, 2021
· 1 min read